lignin has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, H; Cordell, GA; Likhitwitayawuid, K; Mahidol, C; Nitayangkura, S; Pezzuto, JM; Ruchirawat, S; Shieh, HL; Somanabandhu, A | 1 |
| García de Quesada, MT; García Gravalos, MD; López, JL; Medarde, M; Pelaez Lamamie de Clairac, R; Puebla, P; Ruiz Lázaro, P; San Feliciano, A | 1 |
2 other study(ies) available for lignin and Leukemia P388
| Article | Year |
|---|---|
1H- and 13C-nmr assignments of phyllanthin and hypophyllanthin: lignans that enhance cytotoxic responses with cultured multidrug-resistant cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Membrane; Cell Survival; Drug Resistance; Drug Synergism; Glycoproteins; Humans; KB Cells; Leukemia P388; Lignans; Lignin; Magnetic Resonance Spectroscopy; Tumor Cells, Cultured; Vinblastine | 1993 |
Synthesis and biological activity of bromolignans and cyclolignans.
Topics: Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Antiviral Agents; Enzyme Inhibitors; Folic Acid Antagonists; Glutathione Transferase; Humans; Leukemia P388; Lignans; Lignin; Mice; Mice, Inbred DBA; Neoplasms, Experimental | 1993 |